A novel mutation in phospholamban causes a mixed hypertrophic and dilated cardiomyopathy phenotype with autosomal dominant inheritance

A novel mutation in phospholamban causes a mixed hypertrophic and dilated cardiomyopathy phenotype with autosomal dominant inheritance

書誌詳細
主要な著者:	Carballo, S, Blair, E, Watkins, H
フォーマット:	Conference item
出版事項:	2004

類似資料

Autosomal dominant familial dilated cardiomyopathy caused by a novel mutation in phospholamban
著者:: Carballo, S, 等
出版事項: (2004)

Autosomal dominant HCM and DCM phenotype caused by a novel mutation in phospholamban
著者:: Carballo, S, 等
出版事項: (2004)

Identification and functional analysis of cardiac troponin I as a novel disease gene in autosomal dominant familial dilated cardiomyopathy
著者:: Carballo, S, 等
出版事項: (2006)

Early onset malignant hypertrophic cardiomyopathy caused by mutations in MYBPC3
著者:: Carballo, S, 等
出版事項: (2003)

Novel mutations in cardiac MYBPC3 causing early onset malignant hypertrophic cardiomyopathy
著者:: Carballo, S, 等
出版事項: (2005)

A rare cause of mixed hypertrophic and dilated phenotype cardiomyopathy – the MELAS syndrome
著者:: Casian Mihnea, 等
出版事項: (2023-09-01)

Novel mutations in cardiac MYPBC3 cause early onset malignant hypertrophic cardiomyopathy (HCM)
著者:: Carballo, S, 等
出版事項: (2005)

Identification and functional characterization of cardiac troponin I as a novel disease gene in autosomal dominant dilated cardiomyopathy.
著者:: Carballo, S, 等
出版事項: (2009)

Novel mutations in cardiac MYBPC3 and early onset malignant hypertrophic cardiomyopathy
著者:: Carballo, S, 等
出版事項: (2005)

Comparison of the functional effects of mutations in troponin T which cause dilated and hypertrophic cardiomyopathies
著者:: Robinson, P, 等
出版事項: (2002)

Autosomal recessive transmission of MYBPC3 mutation results in malignant phenotype of hypertrophic cardiomyopathy.
著者:: Yilu Wang, 等
出版事項: (2013-01-01)

Structures of PKA–phospholamban complexes reveal a mechanism of familial dilated cardiomyopathy
著者:: Juan Qin, 等
出版事項: (2022-03-01)

Mutations in cis can confound genotype-phenotype correlations in hypertrophic cardiomyopathy.
著者:: Blair, E, 等
出版事項: (2001)

Double mutations in CIS can confound genotype-phenotype correlations in hypertrophic cardiomyopathy
著者:: Blair, E, 等
出版事項: (2000)

Genetic clues to disease pathways in hypertrophic and dilated cardiomyopathies.
著者:: Watkins, H
出版事項: (2003)

Ascertainment strategies and genotype:phenotype correlations in hypertrophic cardiomyopathy.
著者:: Blair, E, 等
出版事項: (2003)

A novel heterozygous missense MYH7 mutation potentially causes an autosomal dominant form of myosin storage myopathy with dilated cardiomyopathy
著者:: Niloofar Naderi, 等
出版事項: (2023-10-01)

Cardiac Steatosis Detected in Hypertrophic Cardiomyopathy, Dilated Cardiomyopathy and Aortic Stenosis
著者:: Suttie, J, 等
出版事項: (2011)

Obesity-related ventricular remodelling is exacerbated in dilated and hypertrophic cardiomyopathy
著者:: Rayner, JJ, 等
出版事項: (2020)

Hypertrophic, Dilated, and Arrhythmogenic Cardiomyopathy: Where Are We?
著者:: Hamza El Hadi, 等
出版事項: (2023-02-01)

Precision and genomic medicine for dilated and hypertrophic cardiomyopathy
著者:: Seitaro Nomura, 等
出版事項: (2023-03-01)

MicroRNAs in Hypertrophic, Arrhythmogenic and Dilated Cardiomyopathy
著者:: Enrica Chiti, 等
出版事項: (2021-09-01)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
著者:: Hudsmith, L, 等
出版事項: (2006)

Dilated cardiomyopathy and the desmin gene.
著者:: Mayosi, B, 等
出版事項: (2000)

Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage.
著者:: Shiv Kumar Viswanathan, 等
出版事項: (2017-01-01)

Investigation of troponin I mutations causing familial hypertrophic cardiomyopathy
著者:: Abdulrazzak, H, 等
出版事項: (2001)

Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments.
著者:: Robinson, P, 等
出版事項: (2007)

Expanding the clinical phenotype of autosomal dominant dyskeratosis congenita caused by TERT mutations
著者:: Lina Basel-Vanagaite, 等
出版事項: (2008-06-01)

Genomic Context Differs Between Human Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy
著者:: Megan J. Puckelwartz, 等
出版事項: (2021-04-01)

Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy.
著者:: Lakdawala, N, 等
出版事項: (2010)

Is Hypertrophic Cardiomyopathy Always a Familial and Inherited Disease?
著者:: Jiri Bonaventura, 等
出版事項: (2023-06-01)

Effects of myosin variants on interacting-heads motif explain distinct hypertrophic and dilated cardiomyopathy phenotypes
著者:: Lorenzo Alamo, 等
出版事項: (2017-06-01)

Phospholamban overexpression in mice causes a centronuclear myopathy-like phenotype
著者:: Val A. Fajardo, 等
出版事項: (2015-08-01)

Digenic Inheritance of LAMA4 and MYH7 Mutations in Patient with Infantile Dilated Cardiomyopathy
著者:: Atiyeh M Abdallah, 等
出版事項: (2019-01-01)

A Case Study Identified a New Mutation in the TTN Gene for Inherited Hypertrophic Cardiomyopathy
著者:: Dong J, 等
出版事項: (2025-01-01)

Desmoplakin mutation underlying autosomal dominant arrhythmogenic cardiomyopathy, palmoplantar keratoderma, and curly hair
著者:: Colin Kincaid, BS, 等
出版事項: (2023-06-01)

Linked genetic modifiers in hypertrophic cardiomyopathy
著者:: Ektisham, J, 等
出版事項: (2004)

Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency.
著者:: Marston, S, 等
出版事項: (2009)

Direct evidence in man for haploinsufficiency as the mechanism of action of myosin-binding protein C mutations that cause hypertrophic cardiomyopathy
著者:: Carballo, S, 等
出版事項: (2008)

Functional effects of mutations in troponin T and tropomyosin which cause dilated cardiomyopathy
著者:: Robinson, P, 等
出版事項: (2003)